Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Biomanufacturing"

36 News Found

Department of Biotechnology hosts webinar on biomanufacturing of enzymes
Biotech | December 28, 2024

Department of Biotechnology hosts webinar on biomanufacturing of enzymes

The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.


Biomanufacturing and Bio-foundry will drive India’s future bioeconomy: Dr. Jitendra Singh
Biotech | March 07, 2024

Biomanufacturing and Bio-foundry will drive India’s future bioeconomy: Dr. Jitendra Singh

India has reached to nearly 6,000 bio-startups from 50 in the past 10 years


Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing
News | April 21, 2022

Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing

Support for biologics manufacturability and Industry 4.0 initiatives


Agilent joins AMBIC to advance biomanufacturing
Medical Device | April 05, 2022

Agilent joins AMBIC to advance biomanufacturing

Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives


WHO establishes biomanufacturing training hub in South Korea
News | February 23, 2022

WHO establishes biomanufacturing training hub in South Korea

Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub


Avantor bags awards at Asia-Pacific Biopharma Excellence Awards 2025
News | April 04, 2025

Avantor bags awards at Asia-Pacific Biopharma Excellence Awards 2025

Awards highlight Avantor's commitment to the Biopharma industry


India’s biotech economy set to reach a massive $300 bn by 2030: Dr. Jitendra Singh
Policy | March 07, 2025

India’s biotech economy set to reach a massive $300 bn by 2030: Dr. Jitendra Singh

Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored


India’s CRDMO sector growth potential at $22 - $25 Billion by 2035: BCG-IPSO Report
News | February 26, 2025

India’s CRDMO sector growth potential at $22 - $25 Billion by 2035: BCG-IPSO Report

Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain


Laurus Labs invests in Laurus Bio
News | December 09, 2024

Laurus Labs invests in Laurus Bio